DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Gerullis H, Bergmann L, Maute L. et al.
Experiences and practical conclusions concerning Temsirolimus
use and adverse events management in advanced renal cell carcinoma within
compassionate use program in Germany.
Cancer Chemother Pharmacol 2008; DOI: 10.1007/s00280-008-0835-2
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.